Shelley B. Thunen, Chief Financial Officer at RxSight, Inc. (RXST), sold 37,795 shares at $49.81 ($1.9M) on 2024-04-01, disclosed to the SEC on 2024-04-02.
Scheduled sale ($1.9M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.81 | 8,938 | $445K | 23.6% |
| 2 | $49.81 | 8,857 | $441K | 23.4% |
| 3 | $49.81 | 8,857 | $441K | 23.4% |
| 4 | $49.81 | 8,938 | $445K | 23.6% |
| 5 | $50.24 | 662 | $33K | 1.8% |
| 6 | $50.27 | 800 |
| $40K |
| 2.1% |
| 7 | $50.37 | 200 | $10K | 0.5% |
| 8 | $51.50 | 543 | $28K | 1.5% |
| Total | $49.85 avg | 37,795 | $1.9M | 100% |
| Filing → |
| RXST | SELL | 2024-05-02 | $1.0M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |
| RXST | SELL | 2024-02-07 | $2.4M | — | Filing → |